Assessment of New Biomarkers in the Management and Triage of Patients With Chest Pain and Suspicion of Non ST Elevation Acute Coronary Syndrome.
Sponsor
Assistance Publique Hopitaux De Marseille (Other)
Overall Status
Completed
CT.gov ID
NCT00769574
Collaborator
(none)
143
1
2
38
3.8
Study Details
Study Description
Brief Summary
To assess diagnostic and prognostic value of new biomarkers in patients admitted for suspicion of non ST elevation acute coronary syndrome (NSTE ACS).
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Actual Enrollment
:
143 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Assessment of New Biomarkers in the Management and Triage of Patients With Chest Pain and Suspicion of Non ST Elevation Acute Coronary Syndrome.
Study Start Date
:
Jun 1, 2008
Actual Primary Completion Date
:
Aug 1, 2011
Actual Study Completion Date
:
Aug 1, 2011
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: 1 Patients with coronary syndrome |
Other: Biological analysis of biomarkers
Biological analysis of biomarkers
|
| Other: 2 Subjects without coronary syndrome |
Other: Biological analysis of biomarkers
Biological analysis of biomarkers
|
Outcome Measures
Primary Outcome Measures
- To assess diagnostic and prognostic value of new biomarkers in patients admitted for suspicion of non ST elevation acute coronary syndrome (NSTE ACS). [24 months]
Secondary Outcome Measures
- Compare the characteristics of biological markers to those of usual or innovative markers [24 months]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
subjects over 18 years,
-
subject about having a chest pain of coronary syndrome,
-
subject about not having received heparin or LMWH
Exclusion Criteria:
-
subject minor
-
subject without informed consent,
-
subject after receiving an anticoagulant treatment,
-
transplanted heart, kidney or liver
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Hôpital de la Timone- Service cardiologie A | Marseille | France | 13385 |
Sponsors and Collaborators
- Assistance Publique Hopitaux De Marseille
Investigators
- Principal Investigator: Jean-Louis BONNET, MD, Assistance Publique des Hôpitaux de Marseille
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Assistance Publique Hopitaux De Marseille
ClinicalTrials.gov Identifier:
NCT00769574
Other Study ID Numbers:
- 2008-A00192-53
First Posted:
Oct 9, 2008
Last Update Posted:
Aug 29, 2014
Last Verified:
Aug 1, 2014